Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

153576724

Orexigen Irony: No VIVUS Bounce

VIVUS Inc. (NASDAQ: VVUS) investors have a lot to be disappointed about these days. America's ballooning waistline is reaching a critical level, yet VIVUS did not even manage to close ...
Read Full Story »
biotech

Biotech Stocks Under $10 With Huge Upside Potential for 2014

Large cap biotech stocks have seen incredible stock performance over the past few years. The problem for many investors is that many of the key stocks have become so expensive ...
Read Full Story »
2014 in the box

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

All of the major firms on Wall Street we cover have prognostications and stock picks for 2014. The Cowen biotechnology team has a list of top 10 surprises that are ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BlackBerry, Micron, SanDisk, VIVUS and More

With the government shut down and with the debt ceiling debate breathing down everyone's neck, investors have to be wondering what they should buy, sell and hold (or even avoid). ...
Read Full Story »
uncertainty market evolution

Jefferies Contrarian Stocks to Buy: Arena, Rackspace and More

It is not unusual to see most research on Wall Street pretty much line up either for or against a company. Analysts typically look at the same metrics in the ...
Read Full Story »
Bull and Bear figures

Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report

U.S. equity markets opened higher this morning following upward revisions from the Bureau of Labor Statistics on non-farm payrolls in February and March and a larger-than-expected rise in payrolls in ...
Read Full Story »
pills

Arena Withdraws Application for Weight-Loss Drug Approval in Europe

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 4, 2013: Markets Open Lower, Rise at End of Day (YHOO, NS, GPS, DF, MRK, ARNA, BYD, SSYS, RIG, YGE, CKP, CEP, FOE, SCSS, SSYS)

U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 1, 2013: Markets Struggle to Small Gains (DB, V, DRI, BUD, ADSK, BODY, CTIC, CLNE, DECK, GPS, MCP, PANW, SD, BBY, ARNA, BYD, SSYS, RIG, GRPN, MTG, IEP)

U.S. equity markets opened lower this morning following a number of disappointing data releases in Europe and Asia. Eurozone PMI remains on the pessimistic side, with a reading of 47.9, ...
Read Full Story »
76764023

VIVUS Obesity Drug Sales Only About 60% of Expectations

VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug ...
Read Full Story »
76764023

Europe Denies Obesity Drug Approval

If you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ACI, ARNA, ADP, IRE, BOH, DELL, FHN, FSLR, FULT, GSS, HSY, INTU, ITRI, JCP, WFR, PNC, RF, SPWR, STP, TCB, USB, VIA, VVUS, WFC)

These are some of this Wednesday's top analyst upgrades, downgrades and initiations seen from Wall S. research calls. We have calls in banks, solar, tech, biotech and more. Arch Coal ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — January 22, 2013: Markets Shake Off Early Doldrums (TWC, SLB, DISH, ARMH, LNKD, DAL, FCX, JNJ, KSU, RF, VZ, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, RIMM, DQ, LDK, ARNA)

U.S. equity markets opened about flat this morning following the holiday weekend in the U.S. Foreign markets were also more or less mixed. In Europe, the German and eurozone economic ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »